Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hoist Finance completes largest portfolio investment ever in acquisition of non-performing mortgage portfolio in France

Hoist Finance has acquired a French non-performing mortgage portfolio with more than 3.500 claims and an outstanding balance of approximately EUR 375 million. This is the largest portfolio investment ever for Hoist Finance. The seller is one of the major banks in France and in Europe and a key partner to Hoist Finance. -     This is the first time a non-performing mortgage portfolio of this size is sold in France. This clearly positions Hoist Finance as a leader within this segment in a very promising market, says Fabien Klecha, Country Manager France and Chief Sales Officer. -

QuickCool AB (publ): European High Growth Opportunities Securitization Fund requests conversion of convertible bonds

European High Growth Opportunities Securitization Fund has by notice to the board of directors of QuickCool AB (Publ) ("QuickCool") called upon its right to conversion of convertible bonds previously issued in accordance with the financing solution announced by QuickCool through a press release on 21 June 2018.QuickCool has received notification from European High Growth Opportunities Securitization Fund regarding conversion of convertible bonds into 714 285 shares in QuickCool, corresponding toSEK 500 000 of the convertible loan. The conversion price per share is SEK 0,70. Upon

Össur hf: Transactions in relation to share buyback program

Announcement no. 78/2019 16 December 2019On 26 November 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 72/2019. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 11 March 2020. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration for shares purchased under the

#19-1166 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#19-1165 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Follicum receives patent grant in the U.S. for stimulation of hair growth using FOL-005

Follicum announced on September 17, 2019 that the Company had received a so-called Notice of Allowance from the US Patent and Trademark Office ("USPTO") regarding the patent application "Novel Compositions and Uses Thereof". Follicum today announces that the patent has now formally been granted by the USPTO. The patent number is US 10,517,932 and the patent is valid until 2032.In this patent family, Follicum already has two granted US patents covering different aspects of FOL-005. Follicum has subsequently submitted a follow-up, so called Continuing Patent Application, which extends and

Gunnebo’s Executive Management Increases Holding Through Call Options

During the last week, certain individuals of Gunnebo’s Executive Management Team have increased their holdings in Gunnebo through investing in call options, issued by the two principal owners Stena Adactum AB and Vätterledens Invest AB, at price equal to the estimated market value. The valuation of the call options has been performed by an independent party according to standard methods. The options have a term of five years.Stefan Syrén, President & CEO, has increased his holdings with 200,000 stock options. His total holding is now 100,000 shares and 250,000 call options. Robert

Herantis Pharma Plc completes patient recruitment and treatment in Phase 2 AdeLE trial in breast cancer associated lymphedema

Herantis Pharma Plc.Company release, insider information 16 December 2019 at 5:00 PM Herantis Pharma Plc (“Herantis” or “Company”) announced today that patient recruitment in the Company’s Phase 2 clinical trial AdeLE (”Adenoviral gene therapy for the treatment of LymphEdema”) has been completed. All of the 39 patients with breast cancer associated lymphedema have been randomized to receive either Lymfactin[®] or placebo treatment, and their treatments have been completed according to the study protocol. The AdeLE trial will continue with a 12-month blinded follow-up to evaluate the

Futility analysis performed of the phase II combination study with birinapant and Keytruda® in colorectal cancer patients

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces today that the independent safety committee (IDMC) for the phase II study of birinapant in combination with pembrolizumab (Keytruda®) in patients with MSS colorectal cancer has performed the planned futility analysis. The primary objective of the phase II study was an improved clinical response to treatment measured as 20% ORR (Overall Response Rate). IDMC's recommendation is that the study should be terminated as the analysis indicates that it is unlikely that the study's objectives will be met. Medivir has therefore decided

We are looking for an HR Business Partner to support our growth in Scandinavia

Kiilto är ett växande familjeägt företag från Finland, med en hundraårig historia och en vision som blickar framåt mot 2080. Vi utvecklar, tillverkar och marknadsför kemiska lösningar för industrin och verkar inom fyra affärsområden: bygg, industriell limningsteknik och hygienlösningar, professionell rengöring och hygien, och konsumentprodukter. Nyckelprinciperna bakom vår verksamhet är miljöledarskap, närhet och framtidsfokus. Vi är ca 1000 anställda, vars välbefinnande och expertis är avgörande för vårt arbete gentemot våra kunder. Vill du skapa ditt eget kapitel i vår hundraåriga

Return of Kamux Corporation’s own shares in accordance with terms and conditions of the share-based incentive scheme 2018

KAMUX CORPORATION    STOCK EXCHANGE RELEASE   16 December 2019 at 16:30 Return of Kamux Corporation’s own shares in accordance with terms and conditions of the share-based incentive scheme 2018 On 13 December 2019 a total of 978 shares have been returned to Kamux Corporation without consideration in accordance with the terms and conditions of the Corporation’s share-based incentive scheme 2018 due to the termination of employment of key person.After the return, Kamux Corporation holds a total of 2,323 of Kamux Corporation’s shares. In Hämeenlinna, 16 December 2019 KAMUX

Elkem receives NOK 50 million in project support

Together with several partners, Elkem has been awarded funding for six projects from The Research Council of Norway in the application round 2019.–The project support helps to solve challenges in the environment, renewable energy and circular economy. The grant from the Research Council is incredibly important, because it triggers investments for research and development and technology development in the industry, says Håvard Moe, Senior Vice President Elkem Technology. Earlier this year, Elkem applied for funding for six projects through the Research Council of Norway's (RCN) scheme for

Handicare Group AB (publ) continues streamlining, divests Handicare Auto A/S

As part of the strategic review communicated in connection with the Q3 report, Handicare today signed an agreement to divest all the shares in Danish company Handicare Auto A/S to Auto Solutions ApS. The divestment of Handicare Auto Denmark is another step in the streamlining of Handicare’s business, focusing on profitable growth.“We believe that Auto Solutions ApS represents a better strategic fit with the business and together with the employees in Handicare Auto Denmark, will continue to develop the business to make it an even stronger partner for its customers and suppliers,” says

Nyfosa acquires a property portfolio at a total value of approximately SEK 4.2 billion – will issue 10,310,000 shares

Nyfosa has signed an agreement with Randviken Fastigheter AB to acquire a property portfolio at a total value of SEK 4.174 billion. The acquisition consists of a portfolio of 79 commercial properties. As part of the purchase price, Nyfosa will issue 10,310,000 new shares.The properties are mainly located in Karlstad but also in Uppsala, Stockholm, Norrköping and Malmö and mainly consists of offices and warehouses. The properties have an area of approximately 286,487 square meters in total and an annual rental value of approximately MSEK 350. The largest tenants are AFRY AB, Meda AB and

Citycon Oyj: Managers’ Transactions

CITYCON OYJ   Managers’ Transactions   16 December 2019 at 16:00 hrsThe acquisition of shares is based on the vesting period of 12 December 2018 to 15 November 2019 in the CEO Restricted Share Plan 2018‒2021. Person subject to the notification requirement: F. Scott Ball, CEOIssuer: Citycon Oyj, LEI 549300P8N0P6KDGTJ206Notification type: initial notificationReference number: 549300P8N0P6KDGTJ206_20191214144758_41) TransactionDate: 12 December 2019Venue: NASDAQ HELSINKI LTD (XHEL)Nature of the transaction: acquisitionInstrumentshare (CTY1S)ISIN Code: FI4000369947

“With Planmeca, I can fully concentrate on my job as a dentist”

Dr Thomas Rosner's initial Planmeca purchase of the Planmeca Emerald™ intraoral scanner in 2018 has been followed by a Planmeca imaging and dental unit, which have impressed Dr Rosner and his team with their effortless usability, high quality and beautiful design. Thanks to Planmeca’s unique all-in-one concept, Dr Rosner is now able to fully concentrate on what he is best at – dentistry. Dr Thomas Rosner offers general and orthodontic dentistry with an emphasis on aligner treatments in his dental clinic  in Tomils, a small village in Graubünden, Switzerland.

Össur hf: Financial calendar 2020

Announcement no. 77/201916 December 2019 Össur’s financial calendar 2020 Interim report Q4 2019 and Annual Report 2019     4 February 2020Annual General Meeting     12 March 2020Interim report Q1 2020     30 April 2020Interim report Q2 2020     23 July 2020Interim report Q3 2020     27 October 2020Interim report Q4 2020 and Annual Report 2020     2 February 2021Annual General Meeting     8 March 2021 Further information David

Norway Royal Salmon ASA (NRS): Sale of shares in Sør Farming AS

With reference to the stock exchange announcement on 26 September 2019, NRS is pleased to announce that the divestment of 100% of the shares in Sør Farming AS to Tombre Fiskeanlegg AS, Lingalaks AS and Eidesvik Laks AS has been completed today. Following a demerger of NRS Farming AS completed on 23 November 2019, Sør Farming AS owns the salmon farming business "Region South" with 4,680 tonnes MAB, that was previously part of NRS Farming AS. In connection with the transaction, the parties have also entered into a long-term cooperation with regards to sale and purchase of fish. DNB

Greater Than partners with ACA, Automobile Club Association France

The Swedish AI-Tech company Greater Than partners with ACA, Automobile Club Association, 1.5 million members, to further reach out with the road safety initiative FIA Smart Driving Challenge. The cooperation aims to engage French organizations and daily motorist to start to drive safer and smarter for the overall road safety and to contribute to lower CO2 emissions in France.“ACA is proud to promote the FIA Smart Driving Challenge, making it fun for the everyday driver to drive in a safe and eco-friendly way. This is also a very great opportunity for us to engage companies and fleets across

ShaMaran Atrush Update

VANCOUVER, BC, December 16, 2019 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (TSX VENTURE: SNM) (NASDAQ FIRST NORTH GROWTH MARKET: SNM) is pleased to report that the Atrush Field has achieved its first day of production at 50,000 barrels since production began in 2017. The current production volumes are subsequent to the completion of CK-15, Atrush’s fourth new production well drilled in 2019. CK-15 came online on the 10thof December and is currently producing at rates over 6,000 barrels per day. Atrush’s annual daily production capacity increased by over 20,000 bopd

Composition of TietoEVRY’s Shareholders’ Nomination Board

TietoEVRY Corporation STOCK EXCHANGE RELEASE 16 December 2019, 3.00 pm EETComposition of TietoEVRY’s Shareholders’ Nomination Board Following the merger between Tieto Corporation and EVRY ASA on 5 December 2019, the composition of the Shareholders’ Nomination Board (SNB) for TietoEVRY Corporation was revised based on holdings in the Finnish, Norwegian and Swedish shareholders’ registers on 9 December 2019. TietoEVRY’s Shareholders' Nomination Board comprises four members nominated by the largest shareholders and the Chairperson of the Board of Directors of the company. The

Walter Frankiewicz of Haldex made new board director of HDMA

Haldex EVP Americas Walter Frankiewicz, was recently nominated and ratified as a member of the Board of Directors for the Heavy Duty Manufacturers Association (HDMA).The HDMA is a division of the Motor Equipment Manufacturers Association (MEMA) and represents the commercial vehicle suppliers' division of MEMA.  Frankiewicz will simultaneously step in as the Vice Chairman of the Heavy Duty Business Forum (HDBF), a working group of the HDMA. By providing his insights and vision for the future, Frankiewicz will now take on a significant role influencing the vision for the future of commercial

Financial calendar for TargetEveryone AB 2020

FINANCIAL YEAR 2019 07.04.2020 - Annual Report 20.05.2020 - Annual General Meeting 18.02.2020 - Quarterly Report - Q4 FINANCIAL YEAR 2020 20.08.2020 - Half-yearly Report 19.05.2020 - Quarterly Report - Q1 10.11.2020 - Quarterly Report - Q3 This information is published pursuant to the requirements set out in the Continuing obligations.   For further information contact: Fredric ForsmanChairman of the Board+46 73 978 78 44 fredric@targeteveryone.com Certified Adviser: Mangold Fondkommission AB (556585-1267) Box 55 691 102 15 Stockholm Telefon:

There are no items matching the current filter
There are no more items matching the current filter
Back to top